Enanta Pharmaceuticals
ENTA
ENTA
148 hedge funds and large institutions have $824M invested in Enanta Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 52 increasing their positions, 40 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
6.43% more ownership
Funds ownership: 66.95% → 73.38% (+6.4%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
148
Holding in Top 10
3
Calls
$1.99M
Puts
–
Top Buyers
| 1 | +$30.1M | |
| 2 | +$15.8M | |
| 3 | +$13M | |
| 4 |
First Manhattan
New York
|
+$8.04M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$6.91M |
Top Sellers
| 1 | -$10.1M | |
| 2 | -$9.21M | |
| 3 | -$9.2M | |
| 4 |
KAM
Krensavage Asset Management
New York
|
-$8.63M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$4.68M |